The Cell & Gene Group at Two Labs

Expert strategy and implementation from the leaders in CGT management

  • Distribution Channel Strategies
  • CGT Channel Strategy Implementation & Account Set-Up 
  • Payer Landscape Assessments 
  • Sites-of-care Research 
  • Implementation and Goal-setting That Keeps CGT Management on Track
  • Established Track Record of Success

Navigating the rapidly evolving CGT landscape

The landscape of Cell & Gene Therapy continues to evolve at a truly breakneck speed. Keeping up with the speed of these changes while effectively managing all the moving pieces of commercializing a highly sophisticated therapy can be immensely challenging – and the stakes are higher than ever.

The Cell & Gene Group at Two Labs provides CGT businesses with tested, proven-by-results strategy and implementation that eliminates the variables in launching and managing CGTs. We provide a wide range of services that position CGT businesses for success, from Payer Landscape Assessments that identify key areas of analysis and research questions to Distribution Channel Strategies that efficiently and effectively deliver life-changing therapies to patients. 

Established track record of success

0 +
distinct companies
0 +
years of combined industry experience
cell & gene drugs supported (launched or in progress)​
0 +
consulting engagements

How We Can Help with CGTs

Channel Strategy & Implementation

Implement the optimal distribution strategy plan to efficiently and effectively get your complex therapy to patients

State Licensing

Ensure regulatory compliance and complete distribution autonomy post-launch

3PL Development, Evaluation, & Selection

Align with the 3PL partner that serves as the best extension of your CGT business for full order-to-cash and distribution services

HUB & Patient Services

Empower patients with the resources and support they need to benefit from new therapies

Gross-to-Net Planning

Build out a comprehensive Cell & Gene Gross to Net Model based on benchmarked data and expert commercial launch strategy

Strategic Consulting 

Unify the medical and business sides of CGT to develop strategic approaches and supporting tactical plans that drive ongoing value creation


Optimize submission timing for expedited data rollout at launch and throughout the CGT lifecycle

EHRx Solutions

Shorten data lags to HCPs and ensure patients receive new therapies as quickly as possible

DSCSA Serialization & Compliance

Insulate your company from federal track & trace non-compliance

Specialty Trade Management

Review Specialty Trade data, identify actionable issues, and resolve them before they arise

Market Access

Determine an optimal payer strategy for new or on market CGTs to optimize access and revenue

Competitive Intelligence

Answer key competitive and market questions that inform better strategic CGT decisions

Let's Get Started.

Additional Cell & Gene Insights

Pricing and Market Access Considerations for Cell and Gene

Adding State Licensing to Your Cell and Gene Launch Strategy

Go to Top